Several studies have shown a correlation between PD-L1 expression in BC samples and multiple clinical and pathological parameters of poor prognosis, including high tumor grade, increased resistance to BCG therapy, and muscle-invasive disease [31,32], although there are discrepancies in the literature on this topic [33]. The gene discussed is CD274; the disease is breast cancer.